The BRCA2 gene is involved in recombinational DNA repair and cytokinesis. BRCA2 defects are associated with chromosomal abnormalities, which is a hallmark of genomic instability that contributes to tumorigenesis. Here, we show that downregulation of a BRCA2 interacting protein (BCCIP) in HT1080 cells leads to chromosomal polyploidization, centrosome amplification and abnormal mitotic spindle formation. The BCCIP knockdown cells can enter mitosis and retain spindle checkpoint, but fail to complete cytokinesis. Our data suggest an essential role of BCCIP in the maintenance of genomic integrity.
Introduction
Human cancers are characteristic of numerical and structural chromosomal instability. Structural chromosome instability, including reciprocal and nonreciprocal translocations, regional chromosomal amplifications/ insertions/deletions, may arise from defects in cell cycle checkpoints, DNA recombination, DNA repair and telomere maintenance. Numerical chromosomal instability (gain or loss of chromosomes) arises from chromosome segregation errors during mitosis, or failure to complete cell separation at the end of mitosis (cytokinesis). Aneuploidy generally results from chromosome segregation errors, which may be a consequence of misregulation of microtubule dynamics, centrosome replication, chromosome condensation, kinetochore assembly, chromosome cohesion and spindle checkpoint control (Lengauer et al., 1998) . A second type of numerical chromosomal abnormality is polyploidization, which may result from failed completion of mitosis followed by a failure of the immediate G1/S checkpoint activation (or tetraploid checkpoint) (Margolis et al., 2003) .
The tumor suppressor gene BRCA2 is involved in homologous recombinational DNA repair that contributes to structural chromosome stability (Moynahan et al., 2001; Venkitaraman, 2002; Powell and Kachnic, 2003) . BRCA2 also participates in the regulation of mitosis and cytokinesis that contribute to numerical chromosomal stability (Daniels et al., 2004; Rudkin and Foulkes, 2005) . BRCA2 interacting protein a (BCCIPa) is a BRCA2 and CDKN1A (p21, Waf1 and Cip1) Interacting Protein (Ono et al., 2000; Liu et al., 2001) . Owing to alternative splicing, a second isoform BCCIPb is expressed in human cells (Meng et al., 2003) . BCCIPa and BCCIPb share identical N-terminal 258 amino acids, but each has a unique C-terminal sequence (Meng et al., 2003) . Additional studies have shown that BCCIPb interacts with BRCA2 and p21 (Meng et al., 2004a; Lu et al., 2005) . The chromatin-bound fraction of BCCIPa/b colocalizes with BRCA2 and contributes to BRCA2 and RAD51 nuclear focus formation (Lu et al., 2005) . A moderate knockdown (B50% of downregulation) of both or either BCCIP isoform significantly reduces DNA double-strand break-induced homologous recombination, impairs G1/S checkpoint activation, abrogates p53 transactivation activities and downregulates p21 expression (Meng et al., 2004a (Meng et al., , b, 2007 Lu et al., 2005) . In this sudy, we show that severely downregulated BCCIP expression results in mitosis defect and chromosome instability in HT1080 cells, suggesting BCCIP as a critical player in maintaining chromosome stability.
Results

BCCIP knockdown causes chromosome instability
In a study when BCCIPa and/or BCCIPb were partially downregulated by RNAi, we observed an increase in polyploid cells after an extended culture of cells with moderate BCCIP knockdown (Supplementary Figure S1) , suggesting a potential role of BCCIP in chromosomal instability. To investigate this, we established cell lines with severe BCCIPa/b knockdown (>95% downregulation) in HT1080 cells by combining two short hairpin RNA (shRNA) targeted at two independent regions of the BCCIPa/b mRNA ( Figure 1a) . Although the growths of these cells are compromised in later stage of culture, the cells can be maintained in culture for a few passages. In these cells, we observed an increase in polyploid cells between passages 2 and 5 ( Figure 1b) . Consistent with this observation, severe BCCIP knockdown induces cells with large or multiple nuclei (Figure 1c ). In addition, we used a chromosome 12-specific centromeric DNA probe to quantify chromosome numbers by fluorescent in situ hybridization (FISH). As shown in Figure 2a and d, control HT1080 cells are mostly diploid. However, the BCCIP knockdown cells displayed a significant increase in cells with more than two copies of chromosome 12 (Figure 2b-d) . These data strongly suggest chromosome instability in cells with severely downregulated BCCIP.
Knockdown of BCCIP does not prevent the entry of G2 cells into M phase Polyploidy can be induced by endoreduplication, by which the cells do not enter mitosis but reenter S-phase after the previous round of DNA replication. Polyploidy can also result from reentry into interphase (and subsequent DNA replication) after a failed cell division in mitosis. To distinguish the potential mechanisms by which BCCIP knockdown induces polyploidization, HT1080 cells were incubated with nocodazole to be blocked at metaphase, and then stained with an pPUR/U6-GFP antibody to Serine-10 phosphorylated histone H3, ph(Ser10)H3, which marks mitotic cells (Hans and Dimitrov, 2001 ). The specificity of this antibody to mitotic cells was confirmed by immunostaining of HT1080 cells (Supplementary Figure S2) . After the DNA was co-stained with propidium iodide, the ph(Ser10)H3 positive cells were scored by flow cytometry. In control cells, ph(Ser10)H3 positive cells accumulate in diploid population but little in tetraploid after nocodazole block ( Figure 3a , b and e). However, in BCCIP knockdown cells, ph(Ser10)H3 positive cells accumulate in both the diploid and tetraploid populations after nocodazole block (Figure 3c -e). The accumulation kinetics of ph(Ser10)H3 positive tetraploid BCCIP knockdown cells is approximately the same as that of the diploid control cells. These data suggest that the BCCIP knockdown cells indeed enter mitosis. They also suggest that BCCIP knockdown cells have normal spindle checkpoint activation as nocodazole effectively blocks cells at metaphase. Therefore, the polyploidization in BCCIP knockdown cells is likely due to a failure of cell division after passing the metaphase (see below), but unlikely due to an endoreduplication of DNA in S phase.
BCCIP knockdown causes cytokinesis failure and centrosome amplification BRCA2 is involved in cytokinesis (Daniels et al., 2004) , and interacts with BCCIP. Because BCCIP knockdown causes polyploidization, which has likely caused a failure of a critical step after the cells have passed the metaphase (Figure 3 ), we investigated whether BCCIP is involved in cytokinesis. We found that BCCIP knockdown significantly increased the percentage of cells with failed cytokinesis (Figure 4 ), suggesting that BCCIP knockdown induces chromosomal polyploidization by impairing cytokinesis, although we cannot exclude the possibility that a small portion of the cells may adopt endoreduplication or abort mitosis at a stage earlier than cytokinesis. It has been suggested that polyploidization may cause centrosome amplification in p53-deficient cells (Meraldi et al., 2002) . We further investigated whether the knockdown of BCCIP can affect centrosomes. As shown in Figure 5a , we indeed observed an increase of cells with abnormal number of centrosomes in BCCIP knockdown cells. In control cells, about 1.2% cells have more than two centrosomes. However, we observed B8% of the BCCIP knockdown cells with more than two centrosomes (Figures 5b). Centrosome amplification was also observed in cells with single BCCIP isoform knockdown (Supplementary Figure S3) . In addition, downregulation of BCCIP induces formation of multipolar mitotic spindles ( Figure 6 ). Centrosome amplification and multipolar mitotic spindles are further evidence of genome instability in BCCIP knockdown cells. Cytokinesis failure and centrosome amplification are immediate events following BCCIP knockdown To determine whether cytokinesis failure and centrosome amplification are the primary consequences of BCCIP knockdown, we transfected a mixture of two independent small interference RNAs (siRNAs) targeted at regions ab311 and ab633 into the cells. The level of BCCIP starts to decline 24 h after transfection, and reaches the lowest level by day 4. However, at day 5 after the transient transfection, the BCCIP level starts to recover (Figure 7c ), which is common when siRNA is transiently transfected into the cells. This may be due to the transient nature of transfected siRNA, or due to a potential fast growth of a non-transfected subpopulation of cells. In these cells with acute BCCIP knockdown, we observed an increase of cytokinesis failure and centrosome amplification as early as 2 days after transfection of BCCIP siRNA (Figure 7a and b) , suggesting that the cytokinesis failure and centrosome amplification are early effects of BCCIP downregulation. These data also show that the kinetics of centrosome amplification and cytokinesis failure (thus tetraploidization) are almost identical in HT1080. Among the cells with more than two centrosomes, about 48% have three or five centrosomes, and 52% have four or six centrosomes, suggesting that the centrosome amplification may also be caused by unbalanced mitotic division. In addition, the method described by Fukasawa et al. (1996) was modified to identify whether centrosome amplification and cytokinesis failure occur during the BCCIP, chromosome instability and cytokinesis X Meng et al first cycle of cell division following release from G0 arrest. Briefly, 1 day after BCCIP siRNA transfection, cell cycle progression was arrested by 0.5% serum starvation for 60 h and then released by changing medium back with 10% serum. Sixteen hours after the release from the G0 arrest, we observed 0.5% of control cells and 8.9% of BCCIP knockdown cells with cytokinesis failure, and 0.7% of control cells and 7.7% of BCCIP knockdown cells with more than two centrosomes. These data suggest that the observed cytokinesis failure and centrosome amplification occur during the immediate round of cell cycle after release from G0 phase. Figure 8a and b). These data further support the role of BCCIP in cytokinesis and centrosome amplification and ruled out off-target effect of BCCIP RNAi on centrosome amplification and cytokinesis failure.
Discussion
In this study, we identified a functional role of BCCIP in numerical chromosome stability in HT1080 cells. We show that BCCIP downregulation causes failure of cytokinesis, centrosome amplification and abnormal spindle formation. These data strongly support a role of BCCIP in the maintenance of genome stability. Because chromosome instability is associated with tumor progression, these findings indicate that loss of BCCIP may be associated with tumor aggression. The human BCCIP gene is located at 10q26 (Liu et al., 2001) , which has been implicated in many forms of human tumors, including astrocytic brain tumors (Rasheed et al., 1992; Maier et al., 1998; Merlo, 2003; Ohgaki et al., 2004) . We have previously shown that BCCIP expression is downregulated in kidney cancer (Meng et al., 2003) , BCCIPa expression was not detectable in astrocytic brain cancer cell line A172 (Liu et al., 2001) , and BCCIP deletion has been suggested in a brain tumor cell line (Roversi et al., 2005) . Recently, we found loss of BCCIP expression in a significant portion of aggressive astrocytic brain tumors (manuscript in preparation), further supporting the role of BCCIP in genomic instability and tumor aggression.
Cells that prematurely exit mitosis must bypass the subsequent G1/S checkpoint (sometimes referred as tetraploidy G1/S checkpoint) before the next DNA replication to become polyploidy (Margolis et al., 2003) . It has been suggested that this G1/S tetraploidy checkpoint is dependent on p53 function (Andreassen et al., 2001) . Thus, the p53 functions may have also been impaired in BCCIP knockdown HT1080 cells. We previously reported that BCCIP knockdown inactivates the G1/S checkpoint (Meng et al., 2004a, b) . Recently, we have shown that the transactivation activity of wildtype p53 is ablated by BCCIP downregulation (Meng et al., 2007) . Therefore, the BCCIP knockdown cells would be able to silence the tetraploidy checkpoint after failed cytokinesis, to bypass G1/S checkpoint and to become susceptible for the next round of DNA replication, all of which leads to polyploidization.
Both aneuploidy and polyploidy are forms of chromosomal instability. The mechanisms by which aneuploidy and polyploidy occur are subtly different. Aneuploidy often results from chromosome segregation errors during mitosis, while polyploidy may be a consequence of failed cytokinesis, DNA endoreduplication or endomitosis as in megakaryocyte differentiation (Geddis and Kaushansky, 2004) . Our data have shown that cytokinesis failure is the major consequence of BCCIP knockdown, which is accompanied by centrosome amplification in the first cell cycle after BCCIP knockdown (Figure 7) . We also observed that some BCCIP knockdown cells have three copies of chromosome (Figure 2d) , suggesting aneuploidy. Although we cannot rule out that the modest-level aneuploidy is a result of chromosome segregation errors, it is unlikely caused by spindle checkpoint defect as nocodazole effectively blocked BCCIP knockdown cells at metaphase (Figure 3) . It is possible that the aneuploidy is a result of abnormal mitotic spindle formations, which are consequence of the centrosome amplification and cytokinesis failure. In addition, some BCCIP knockdown cells have more than two and unpaired (such as three or five) centrosomes. This would add further mechanism for aneuploidy formation.
BRCA2 is involved in cytokinesis and homologous recombination (Moynahan et al., 2001; Venkitaraman, 2002; Powell and Kachnic, 2003; Daniels et al., 2004) . We have previously reported that chromatin-bound fraction of BCCIP colocalizes with BRCA2, and a modest knockdown of BCCIP (B50% of BCCIP reduction) reduces DNA double-strand break-induced homologous recombination (Lu et al., 2005) . In this study, we show that BCCIP is involved in cytokinesis and chromosomal stability. Therefore, BCCIP may regulate the maintenance of genome stability through multiple pathways: homologous recombinational repair (Lu et al., 2005) , G1/ S checkpoint (Meng et al., 2004a, b) and cytokinesis. It remains to be determined whether the interaction between BRCA2 and BCCIP plays a direct role in cytokinesis. In addition, it has been reported that p53 protein has both transcription-dependent and -independent role in preventing centrosome amplification (Tarapore et al., 2001; Tarapore and Fukasawa, 2002; Shinmura et al., 2006) , and the transcriptional-dependent function of p53 in centrosome amplification is likely mediated by p21 (Tarapore et al., 2001) and BCCIP interacts with p21 (Meng et al., 2004a, b) and BCCIP down-regulation abrogates the transcriptional activity of p53 (Meng et al., 2007) . It is possible that BCCIP may regulate centrosome stability through p53 and p21 functions. 
Materials and methods
Cell culture HT1080 cells were cultured in aMEM (Gibco BRL, Grand Island, NY, USA) with 10% fetal bovine serum (Biowhittaker, Walkersville, MD, USA), 20 mM glutamine and 1% penicillin/ streptomycin (Gibco BRL). Plasmids were transfected into cells using the Geneporter transfection kit (Gene Therapy Systems Inc., San Diego, CA, USA). Flag-BCCIP expression in HT1080 cells were mediated by the pLXSP vector-based retrovirus infection as reported previously (Liu et al., 2001) .
Antibodies and Western blot
Rabbit anti-BCCIPa/b antibodies were reported previously (Liu et al., 2001) . Other antibodies were purchased as: antiSer-10 phosphorylated histone H3 (ph(Ser10)H3) antibodies from Upstate (Lake Placid, NY, USA); anti-b-actin and antia-tubulin antibodies from Sigma (St Louis, MO, USA); and anti-pericentrin antibody from Covance Research Products Inc. (Berkeley, CA, USA). Protein extracts were prepared from cells lysed with 50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, pH 7.6, 250 mM NaCl, 5 mM ethylenediaminetetraacetic acid and 0.1% Nonidet P-40. Proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and Western blotting was performed as described (Meng et al., 2004a, b) . Anti-flag antibody was purchased from Sigma.
Immunocytochemistry
Cells grown on coverslips were washed with phosphatebuffered saline (PBS), and fixed with methanol. The fixed cells were washed with Tris buffered saline with Tween-20 (TBS-T) (25 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% Tween-20) three times and blocked for 30 min with 3% bovine serum albumin (BSA) in TBS-T. Cells were incubated in rabbit antipericentrin (1:300), or mouse anti-a-tubulin (1:300) primary antibody diluted in 3% BSA blocking buffer at 41C overnight. After washing three times with TBS-T, cells on coverslips were incubated with appropriate secondary antibodies conjugated with fluorescein (FITC) or Texas Red (Jackson ImmunoResearch, West Grove, PA, USA) for 1 h at room temperature in the dark, washed and mounted using mounting medium containing 4 0 ,6-diamidino-2-phenylindole (DAPI). The images were recorded using a Zeiss fluorescence microscopy with an Axioskop digital camera.
Knockdown of BCCIP expression by shRNA
We used two vectors to express shRNA to knockdown BCCIP expression. The plasmid pPUR/U6 uses a puromycin resistance cassette, while the pSilencer2.1Hyg (Ambion Inc., Austin, TX, USA) uses hygromycin B as the selection marker. The control vectors express either a scrambled sequence 5 0 -ACT ACC GTT GTT ATA GGT G-3 0 (Ambion Inc.) in pSilencer2.1Hygomycin or a GFP cDNA target sequences 5 0 -GGT TAT GTA CAG GAA CGC A-3 0 in pPUR/U6. The isoform specific BCCIP silencing has been reported (Lu et al., 2005) . Briefly, isoform-specific sequences targeting BCCIPa (5 0 -GGG AAC CTT CAT GAC TGT TGG) or BCCIPb (5 0 -GGG AAG CAA ATG GTC TTT TGA) were inserted into pPUR/U6. To knockdown both BCCIPa and BCCIPb isoforms, several shRNA sequences targeted at the shared region of BCCIPa and BCCIPb were used, including: shRNA-ab311 (5 0 -GTG TGA TTA AGC AAA CGG AT G-3 0 ), shRNA-ab633 (5 0 -GCC ATG TGG GAA GTG CTA C-3 0 ), and shRNA-ab730 (5 0 -GCT GCG TTA ATG TTT GCA AAT-3 0 ). We found that application of a single shRNA can only cause B50% downregulation of BCCIP (Figure 1a) , which is referred as 'moderate knockdown' in this study. To knockdown BCCIPa/b further, we combined two shRNAs: ab311 and ab633 or ab311 and ab730, creating B95% downregulation of BCCIP (Figure 1a) , referred as 'severe knockdown' condition in this study. Briefly, HT1080 cells were transfected with pPUR/U6 (with puromycin as selection marker) vectors expressing either control or BCCIP shRNAab311, and then selected in puromycin for 2 weeks. The puromycin-resistant cells were further transfected with pSilencer2.1 (with hygomycin as the selection marker) control or BCCIP shRNA-ab633 or shRNA-ab730 vectors and selected by hygromycin B. After 2 weeks' selection, puromycin and hygromycin double-resistant HT1080 cells with BCCIP severe knockdown were established and designated as passage 1. Cells were passed every 3 days and cultured in the medium containing both puromycin and hygromycin.
Acute knockdown of BCCIP expression by siRNA The siRNA was synthesized by in vitro transcription according to the protocol of the manufacturer (Ambion Inc.). The firefly luciferase control siRNA 5 0 -CTT ACG CTG AGT ACT TCG A-3 0 was used as negative control. The BCCIPa 3 0 -terminusuntranslated region-specific siRNA is 5 0 -AAC ATC TCG GCA CCT AGT AAT-3 0 . The BCCIPb 3 0 -terminus untranslated region specific siRNA is 5 0 -AAC TCA GAC TTT ATT CAG ATT AA-3 0 . siRNA was transfected by lipofectamine (Gibco BRL, Rockville, MD, USA).
Flow cytometry analysis DNA content analysis by flow cytometry has been described previously (Meng et al., 2004a, b, c) . Cells were fixed with 70% ethanol overnight, washed with PBS and incubated with mouse anti-ph(Ser10)H3 antibody (1:200 dilution). After washing, these cells were incubated with FITC-conjugated anti-mouse immunoglobulin before analysed by flow cytometry to score ph(Ser10)H3 positive cells.
FISH analysis of chromosomes
A chromosome 12-specific centromeric FISH probe (Vysis Inc., Downers Grove, IL, USA) was used to hybridize HT1080 cells according to the manufacturer's protocol with high stringent washing condition.
